Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 81,970 shares at $91.98 ($7.5M) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Open-market sale of $7.5M MIRM by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.98 | 40,985 | $3.8M | 50.0% |
| 2 | $91.98 | 40,985 | $3.8M | 50.0% |
| Total | $91.98 avg | 81,970 | $7.5M | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-02-03 | $941K | — | Filing → |